Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

LUPIN vs GLENMARK PHARMA - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    LUPIN GLENMARK PHARMA LUPIN/
GLENMARK PHARMA
 
P/E (TTM) x 40.7 -31.4 - View Chart
P/BV x 6.0 2.9 209.5% View Chart
Dividend Yield % 0.2 0.3 94.7%  

Financials

 LUPIN   GLENMARK PHARMA
EQUITY SHARE DATA
    LUPIN
Mar-23
GLENMARK PHARMA
Mar-23
LUPIN/
GLENMARK PHARMA
5-Yr Chart
Click to enlarge
High Rs799487 164.0%   
Low Rs583349 167.1%   
Sales per share (Unadj.) Rs365.8460.4 79.5%  
Earnings per share (Unadj.) Rs9.813.4 73.6%  
Cash flow per share (Unadj.) Rs29.235.0 83.3%  
Dividends per share (Unadj.) Rs4.002.50 160.0%  
Avg Dividend yield %0.60.6 96.8%  
Book value per share (Unadj.) Rs270.7335.1 80.8%  
Shares outstanding (eoy) m454.98282.17 161.2%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x1.90.9 208.0%   
Avg P/E ratio x70.231.3 224.7%  
P/CF ratio (eoy) x23.711.9 198.4%  
Price / Book Value ratio x2.61.2 204.7%  
Dividend payout %40.718.7 217.5%   
Avg Mkt Cap Rs m314,381117,953 266.5%   
No. of employees `000NANA-   
Total wages/salary Rs m30,87227,810 111.0%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m166,417129,901 128.1%  
Other income Rs m1,5093,168 47.6%   
Total revenues Rs m167,926133,069 126.2%   
Gross profit Rs m17,20615,125 113.8%  
Depreciation Rs m8,8076,113 144.1%   
Interest Rs m2,7433,496 78.5%   
Profit before tax Rs m7,1658,685 82.5%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m2,6884,911 54.7%   
Profit after tax Rs m4,4773,774 118.6%  
Gross profit margin %10.311.6 88.8%  
Effective tax rate %37.556.5 66.3%   
Net profit margin %2.72.9 92.6%  
BALANCE SHEET DATA
Current assets Rs m124,51398,737 126.1%   
Current liabilities Rs m92,65450,455 183.6%   
Net working cap to sales %19.137.2 51.5%  
Current ratio x1.32.0 68.7%  
Inventory Days Days267 391.4%  
Debtors Days Days98115 85.3%  
Net fixed assets Rs m103,49076,920 134.5%   
Share capital Rs m910282 322.5%   
"Free" reserves Rs m122,24694,281 129.7%   
Net worth Rs m123,15694,563 130.2%   
Long term debt Rs m27538,521 0.7%   
Total assets Rs m228,003175,658 129.8%  
Interest coverage x3.63.5 103.7%   
Debt to equity ratio x00.4 0.5%  
Sales to assets ratio x0.70.7 98.7%   
Return on assets %3.24.1 76.5%  
Return on equity %3.64.0 91.1%  
Return on capital %8.09.2 87.7%  
Exports to sales %00-   
Imports to sales %00-   
Exports (fob) Rs mNANA-   
Imports (cif) Rs mNANA-   
Fx inflow Rs m48,05746,464 103.4%   
Fx outflow Rs m21,75212,712 171.1%   
Net fx Rs m26,30633,751 77.9%   
CASH FLOW
From Operations Rs m18,9726,254 303.4%  
From Investments Rs m-12,868-5,285 243.5%  
From Financial Activity Rs m-3,373-775 435.4%  
Net Cashflow Rs m2,732325 840.7%  

Share Holding

Indian Promoters % 46.8 46.7 100.2%  
Foreign collaborators % 0.3 0.0 -  
Indian inst/Mut Fund % 45.8 34.7 132.2%  
FIIs % 16.1 23.7 67.9%  
ADR/GDR % 0.0 0.0 -  
Free float % 53.0 53.4 99.3%  
Shareholders   281,542 209,931 134.1%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare LUPIN With:   SUN PHARMA    DIVIS LABORATORIES    CIPLA    DR. REDDYS LAB    ZYDUS LIFESCIENCES    


More on Lupin vs Glenmark Pharma

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

Lupin vs Glenmark Pharma Share Price Performance

Period Lupin Glenmark Pharma S&P BSE HEALTHCARE
1-Day 1.23% -0.57% 1.18%
1-Month 0.15% 5.16% -0.75%
1-Year 151.14% 112.94% 61.82%
3-Year CAGR 17.13% 27.51% 18.16%
5-Year CAGR 17.42% 8.05% 19.79%

* Compound Annual Growth Rate

Here are more details on the Lupin share price and the Glenmark Pharma share price.

Moving on to shareholding structures...

The promoters of Lupin hold a 47.0% stake in the company. In case of Glenmark Pharma the stake stands at 46.7%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of Lupin and the shareholding pattern of Glenmark Pharma.

Finally, a word on dividends...

In the most recent financial year, Lupin paid a dividend of Rs 4.0 per share. This amounted to a Dividend Payout ratio of 40.7%.

Glenmark Pharma paid Rs 2.5, and its dividend payout ratio stood at 18.7%.

You may visit here to review the dividend history of Lupin, and the dividend history of Glenmark Pharma.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising(Closing)

After opening the day on positive note, Indian share markets gained the momentum as the session progressed and ended on firm footing.